Search
Patexia Community
News and Analysis

Our Members

All »
R S
omid sharifi
Genevieve Victoria Kayat
Mohamed Fasly
Kourosh Salehi
shash sen
Rajeeva Musunuri
Jessie S
Kun-Bin Hsieh
lalit kumar
shimaa osama
Valer Rodak
Hye Jung Jang
Brian Smirke
Pedram Lajevardi

Innovation, Technology, and IP News

If a Case Was Baseless, It Would Have Ended Sooner

Written by: Matthew Pham & Daniel P. Hughes OneSubsea IP UK Limited v. FMC Technologies, Inc. Before Clevenger, Moore, and Dyk.  Appeal from the United States District...

Low-Bar for Corroboration

Written by: Matthew Friedrichs & Daniel P. Hughes MEDTRONIC, INC. v. TELEFLEX INNOVATIONS S.A.R.L. Before Moore, Lourie, and Dyk. Appeal from the Patent Trial and Appeal...

Trademark Monitoring and Enforcement in the Digital Era: Tools and Techniques

In today's digital landscape, protecting your trademarks has become more challenging than ever before. With the rise of e-commerce platforms, social media, and online marketplaces, ...

Exploring the Use of Machine Learning in Prior Art Search: Advancing Patent Examination Efficiency

In the realm of patent examination, the search for prior art plays a critical role in determining the novelty and inventiveness of an invention. Traditionally, patent examiners...

Recessions and Patent Applications: Navigating the Ups and Downs of the Innovation Economy

Written by: Sophia Petrichenko & Jason J. Jardine As predictions of an economic recession in the United States loom, 2023 has started with extensive layoffs throughout the...

Feed tagged as "pfizer":
Pfizer and BioNTech Strike Back to CureVac's Lawsuit by Seeking Declaratory Judgment of Noninfringement | Who Will Control mRNA Tech?
Mikele Bicolli Aug 28, 2022
Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for emergency use by FDA... Read More »
Comment: 0 Favorite (0)
Pfizer and BioNTech Sued Again Over Covid Vaccine Technology, This Time by Moderna
Mikele Bicolli Aug 27, 2022
Less than two months ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent... Read More »
Comment: 0 Favorite (0)
The FDA approves new Pfizer drug to treat kidney cancer
Elisabeth Manville Jan 27, 2012
Pfizer announced that the U.S. Food and Drug Administration has approved their kidney cancer drug INLYTA (axinib). The treatment will be available for patients... Read More »
Comment: 0 Favorite (0)
World Intellectual Property Organization holds an innovation consortium
Alejandro Freixes Oct 25, 2011
  GENEVA (Reuters) - The World Intellectual Property Organization launched a consortium on Wednesday that would allow the public and private sector to... Read More »
Comment: 0 Favorite (0)
Studies show no extra risk with Pfizer smoking drug
Alejandro Freixes Oct 23, 2011
  (Reuters) - Smokers who take Pfizer's pill Chantix to help them quit do not have a higher risk of being hospitalized for psychiatric events such as... Read More »
Comment: 0 Favorite (0)
Menu